• Toll Free: +1- 844-445-2861

Global Cancer Biomarker Market Report, History and Forecast 2013-2025, Breakdown Data by Companies, Key Regions, Types and Application

Report ID
Category
Pages
Reporting status

Licence Type

Please choose the suitable license type from above.

Description

This report studies the Cancer Biomarker market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Cancer Biomarker market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of between 2018 and 2025.

This report focuses on the global top players, covered

Abbott Laboratories
F.Hoffmann-La Roche Ltd.
QIAGEN
Thermo Fisher Scientific Inc.
Affymetrix Inc.
Illumina, Inc.
Agilent Technologies
Merck & Co. Inc.
Hologic, Inc.
Sino Biological Inc.
Becton, Dickinson and Company

Market segment by Regions/Countries, this report covers

North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into

Genetic Biomarkers
Epigenetic Biomarkers
Metabolic Biomarkers
Proteomic Biomarkers
Others

Market segment by Application, the market can be split into

Drug discovery and Development
Diagnostics
Personalized medicine
Others

The study objectives of this report are:

To study and forecast the market size of Cancer Biomarker in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cancer Biomarker are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Table of Content

Cancer Biomarker Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Cancer Biomarker
    1.1 Cancer Biomarker Market Overview
        1.1.1 Cancer Biomarker Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Cancer Biomarker Market Size and Analysis by Regions
        1.2.1 North America
        1.2.2 Europe
        1.2.3 China
        1.2.4 Rest of Asia Pacific
        1.2.5 Central & South America
        1.2.6 Middle East & Africa
    1.3 Cancer Biomarker Market by Type
        1.3.1 Genetic Biomarkers
        1.3.2 Epigenetic Biomarkers
        1.3.3 Metabolic Biomarkers
        1.3.4 Proteomic Biomarkers
        1.3.5 Others
    1.4 Cancer Biomarker Market by End Users/Application
        1.4.1 Drug discovery and Development
        1.4.2 Diagnostics
        1.4.3 Personalized medicine
        1.4.4 Others

2 Global Cancer Biomarker Competition Analysis by Players
    2.1 Cancer Biomarker Market Size (Value) by Players (2017 and 2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Abbott Laboratories
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.1.5 Recent Developments
    3.2 F.Hoffmann-La Roche Ltd.
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.2.5 Recent Developments
    3.3 QIAGEN
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.3.5 Recent Developments
    3.4 Thermo Fisher Scientific Inc.
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.4.5 Recent Developments
    3.5 Affymetrix Inc.
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.5.5 Recent Developments
    3.6 Illumina, Inc.
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.6.5 Recent Developments
    3.7 Agilent Technologies
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.7.5 Recent Developments
    3.8 Merck & Co. Inc.
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.8.5 Recent Developments
    3.9 Hologic, Inc.
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.9.5 Recent Developments
    3.10 Sino Biological Inc.
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Cancer Biomarker Revenue (Value) (2013-2018)
        3.10.5 Recent Developments
    3.11 Becton, Dickinson and Company

4 Global Cancer Biomarker Market Size by Type and Application (2013-2018)
    4.1 Global Cancer Biomarker Market Size by Type (2013-2018)
    4.2 Global Cancer Biomarker Market Size by Application (2013-2018)
    4.3 Potential Application of Cancer Biomarker in Future
    4.4 Top Consumer/End Users of Cancer Biomarker

5 North America Cancer Biomarker Development Status and Outlook
    5.1 North America Cancer Biomarker Market Size (2013-2018)
    5.2 North America Cancer Biomarker Market Size and Market Share by Players (2017 and 2018)

6 Europe Cancer Biomarker Development Status and Outlook
    6.1 Europe Cancer Biomarker Market Size (2013-2018)
    6.2 Europe Cancer Biomarker Market Size and Market Share by Players (2017 and 2018)

7 China Cancer Biomarker Development Status and Outlook
    7.1 China Cancer Biomarker Market Size (2013-2018)
    7.2 China Cancer Biomarker Market Size and Market Share by Players (2017 and 2018)

8 Rest of Asia Pacific Cancer Biomarker Development Status and Outlook
    8.1 Rest of Asia Pacific Cancer Biomarker Market Size (2013-2018)
    8.2 Rest of Asia Pacific Cancer Biomarker Market Size and Market Share by Players (2017 and 2018)

9 Central & South America Cancer Biomarker Development Status and Outlook
    9.1 Central & South America Cancer Biomarker Market Size (2013-2018)
    9.2 Central & South America Cancer Biomarker Market Size and Market Share by Players (2017 and 2018)

10 Middle East & Africa Cancer Biomarker Development Status and Outlook
    10.1 Middle East & Africa Cancer Biomarker Market Size (2013-2018)
    10.2 Middle East & Africa Cancer Biomarker Market Size and Market Share by Players (2017 and 2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Cancer Biomarker Market Size (Value) by Regions (2018-2025)
        11.1.1 North America Cancer Biomarker Revenue and Growth Rate (2018-2025)
        11.1.2 Europe Cancer Biomarker Revenue and Growth Rate (2018-2025)
        11.1.3 China Cancer Biomarker Revenue and Growth Rate (2018-2025)
        11.1.4 Rest of Asia Pacific Cancer Biomarker Revenue and Growth Rate (2018-2025)
        11.1.5 Central & South America Cancer Biomarker Revenue and Growth Rate (2018-2025)
        11.1.6 Middle East & Africa Cancer Biomarker Revenue and Growth Rate (2018-2025)
    11.2 Global Cancer Biomarker Market Size (Value) by Type (2018-2025)
    11.3 Global Cancer Biomarker Market Size by Application (2018-2025)

12 Cancer Biomarker Market Dynamics
    12.1 Cancer Biomarker Market Opportunities
    12.2 Cancer Biomarker Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Cancer Biomarker Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Cancer Biomarker Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Cancer Biomarker Product Scope
    Figure Global Cancer Biomarker Market Size (Million USD) (2013-2018)
    Table Global Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Global Cancer Biomarker Market Share by Regions in 2017
    Figure North America Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Europe Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Rest of Asia Pacific Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Central & South America Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Middle East & Africa Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Global Cancer Biomarker Market Share by Type in 2017
    Figure Genetic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Epigenetic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Metabolic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Proteomic Biomarkers Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Cancer Biomarker Market Share by Application in 2017
    Table Key Downstream Customer in Drug discovery and Development
    Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Drug discovery and Development (2013-2018)
    Table Key Downstream Customer in Diagnostics
    Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Diagnostics (2013-2018)
    Table Key Downstream Customer in Personalized medicine
    Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Personalized medicine (2013-2018)
    Table Key Downstream Customer in Others
    Figure Cancer Biomarker Market Size (Million USD) and Growth Rate in Others (2013-2018)
    Table Cancer Biomarker Market Size (Million USD) by Players (2017 and 2018)
    Figure Cancer Biomarker Market Size Share by Players in 2017
    Figure Cancer Biomarker Market Size Share by Players in 2018
    Table Abbott Laboratories Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Abbott Laboratories (2013-2018)
    Figure Abbott Laboratories Cancer Biomarker Business Revenue Market Share in 2017
    Table F.Hoffmann-La Roche Ltd. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of F.Hoffmann-La Roche Ltd. (2013-2018)
    Figure F.Hoffmann-La Roche Ltd. Cancer Biomarker Business Revenue Market Share in 2017
    Table QIAGEN Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of QIAGEN (2013-2018)
    Figure QIAGEN Cancer Biomarker Business Revenue Market Share in 2017
    Table Thermo Fisher Scientific Inc. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Thermo Fisher Scientific Inc. (2013-2018)
    Figure Thermo Fisher Scientific Inc. Cancer Biomarker Business Revenue Market Share in 2017
    Table Affymetrix Inc. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Affymetrix Inc. (2013-2018)
    Figure Affymetrix Inc. Cancer Biomarker Business Revenue Market Share in 2017
    Table Illumina, Inc. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Illumina, Inc. (2013-2018)
    Figure Illumina, Inc. Cancer Biomarker Business Revenue Market Share in 2017
    Table Agilent Technologies Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Agilent Technologies (2013-2018)
    Figure Agilent Technologies Cancer Biomarker Business Revenue Market Share in 2017
    Table Merck & Co. Inc. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Merck & Co. Inc. (2013-2018)
    Figure Merck & Co. Inc. Cancer Biomarker Business Revenue Market Share in 2017
    Table Hologic, Inc. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Hologic, Inc. (2013-2018)
    Figure Hologic, Inc. Cancer Biomarker Business Revenue Market Share in 2017
    Table Sino Biological Inc. Basic Information List
    Table Cancer Biomarker Business Revenue (Million USD) of Sino Biological Inc. (2013-2018)
    Figure Sino Biological Inc. Cancer Biomarker Business Revenue Market Share in 2017
    Table Becton, Dickinson and Company Basic Information List
    Table Global Cancer Biomarker Market Size (Million USD) by Type (2013-2018)
    Figure Global Cancer Biomarker Market Size Share by Type in 2013
    Figure Global Cancer Biomarker Market Size Share by Type in 2014
    Figure Global Cancer Biomarker Market Size Share by Type in 2015
    Figure Global Cancer Biomarker Market Size Share by Type in 2016
    Figure Global Cancer Biomarker Market Size Share by Type in 2017
    Figure Global Cancer Biomarker Market Size Share by Type in 2018
    Table Global Cancer Biomarker Market Size (Million USD) by Application (2013-2018)
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2013
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2014
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2015
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2016
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2017
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2018
    Table Top Consumer/End Users of Cancer Biomarker
    Figure North America Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table North America Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
    Figure North America Cancer Biomarker Market Size Share by Players in 2017
    Figure North America Cancer Biomarker Market Size Share by Players in 2018
    Figure Europe Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Europe Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
    Figure Europe Cancer Biomarker Market Size Share by Players in 2017
    Figure Europe Cancer Biomarker Market Size Share by Players in 2018
    Figure China Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table China Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
    Figure China Cancer Biomarker Market Size Share by Players in 2017
    Figure China Cancer Biomarker Market Size Share by Players in 2018
    Figure Rest of Asia Pacific Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Rest of Asia Pacific Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
    Figure Rest of Asia Pacific Cancer Biomarker Market Size Share by Players in 2017
    Figure Rest of Asia Pacific Cancer Biomarker Market Size Share by Players in 2018
    Figure Central & South America Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Central & South America Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
    Figure Central & South America Cancer Biomarker Market Size Share by Players in 2017
    Figure Central & South America Cancer Biomarker Market Size Share by Players in 2018
    Figure Middle East & Africa Cancer Biomarker Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Middle East & Africa Cancer Biomarker Market Size (Million USD) by Players (2013-2018)
    Figure Middle East & Africa Cancer Biomarker Market Size Share by Players in 2017
    Figure Middle East & Africa Cancer Biomarker Market Size Share by Players in 2018
    Figure Global Cancer Biomarker Market Size (Million USD) by Regions (2018-2025)
    Table Global Cancer Biomarker Market Size (Million USD) by Regions (2018-2025)
    Figure Global Cancer Biomarker Market Size Share by Regions in 2018
    Figure Global Cancer Biomarker Market Size Share by Regions in 2025
    Figure North America Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Europe Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Rest of Asia Pacific Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Central & South America Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Middle East & Africa Cancer Biomarker Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Cancer Biomarker Market Size (Million USD) by Type (2018-2025)
    Figure Global Cancer Biomarker Market Size Share by Type in 2018
    Figure Global Cancer Biomarker Market Size Share by Type in 2025
    Table Global Cancer Biomarker Market Size (Million USD) by Application (2018-2025)
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2018
    Figure Global Cancer Biomarker Market Size (Million USD) by Application in 2025
 

Research Methodology

The research study include the involvement of wide range of secondary sources; databases; directories which include Bloomberg Business, Hoovers, Factiva, and Avention; annual reports, white papers; company house documents; and SEC filings of companies. Secondary research is majorly used to identify and collect information valuable for the extensive, technical, market-oriented, and commercial study of the market. The method was also used for obtaining the key information related to market classification and segmentation according to the industry trends, regional markets, and developments related to the market and technology perspectives.

Primary sources are majorly several industry experts from core and related industries; and preferred suppliers, distributors, suppliers, manufacturers, technology developers, service providers, researchers and organizations associated to all segments of the industry’s value chain. Detailed interviews were also conducted from various primary respondents which included key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure shows the market research methodology applied in making this report.

Once the market engineering is completed (which includes calculations for market statistics, market breakdown, market size estimation, market forecasting, and data triangulation) extensive primary research was conducted to gather information and to verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types and key market dynamics such as drivers, restraints, and opportunities.

The complete market engineering process, both top-down and bottom-up approaches were comprehensively utilized with various data triangulation methods for performing market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list key information/insights throughout the report.

Request Customization

Custom Reasearch

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.

Please Fill In The Customization Form With Your Requirements.

Help

Email Address :

[email protected]

Toll Free :

+1- 844-445-2861

  • USA Office

    244 , Madison Avenue
    New York City, NY - 10016
    United States


    UK Office

    109 ,Straford Street,Leeds
    West Yorkshrie LS11 6JG
    United Kingdom

Copyright © 2018-19 futuregenicreports.com. All rights reserved.